An increased hepatic BA production and diarrhea were associated with an increased NAFLD score, but not a low FGF19, indicating dysregulation of the FXR-FGF19 axis. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.